Navigation Links
Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry

SANTA CLARA, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign, a proprietary method of straightening teeth without wires or brackets, today announced approval of its Continuing Education Program by the Academy of General Dentistry's (AGD) Program Approval for Continuing Education (PACE) Committee.

PACE is an evaluation of the educational processes used in designing, planning and implementing continuing education. It was created to assist the dental profession in identifying and participating in quality continuing dental education.

"We are pleased that the AGD has approved our program, and in so doing, has recognized our dedication to continuing education," said Dr. Lou Shuman, vice president of strategic relations for Align. "Our acceptance in the dental community has been a direct result of the commitment we have to educating providers on the applicability of the Invisalign technique in their practice, and the general benefits it provides to their patients."

Align's Clinical Education department is working to provide a "True Continuum of Learning." The team's goal is to create diverse educational resources for Invisalign providers -- from the novice to the most advanced practitioner -- in a wide variety of delivery formats, thereby accommodating each customer's unique learning preferences.

To be considered for PACE, organizations that are national or international in scope, providing programs in more than one state or province or drawing a significant amount of participants from more than one state or province, submit applications that are then reviewed by a nine-member committee. Program providers must adhere to over one dozen published standards and criteria in different areas to receive and maintain approval status.

"Align has an incredible team that is dedicated to creating and managing the significant amount of education they provide each year," said AGD President Vincent C. Mayher, DMD, MAGD. "The PACE approval is recognition of Align's professional commitment to continuing education, both now and in the future."

Program providers approved through the AGD are approved to offer credit hours that can be applied towards the AGD's Fellowship (FAGD) and Mastership (MAGD) award programs. Currently, just under 500 program providers have received national approval by the AGD's PACE Committee.

The AGD is a professional association of more than 33,000 general dentists dedicated to staying up-to-date in the profession through continuing education. Founded in 1952, the AGD has grown to become the world's second largest dental association, which is the only association that exclusively represents the needs and interests of general dentists. A general dentist is the primary care provider for patients of all ages and is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs. Visit

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

SOURCE Align Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. A better test than cytology for Urinary Malignancy
2. Blood test developed for malignant hyperthermia
3. Malignant Mesothelioma – A New Genetic Revelatio
4. Malignant Mesothelioma – A New Genetic Revelation
5. Malignant virus in polio vaccine combined to Cancer
6. Indian Researcher Discovers Reason For Malignancy of Skin Cancer
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Seattle, a hub for malignant melanoma? Time To Get Sunwise!
9. Protein Involved In Embryo Formation Found In Malignant Cells
10. When Her Lot is maligned by HER-2, Staying Abreast is Imperative
11. Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... Key Housing, a top-rated corporate housing ... December, 2015, featured apartment community: Epic. In showcasing this featured apartment community in San ... Bay Area rental market to efficiently find housing suitable to their needs by showcasing ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back ... to choose from, the possibilities are endless. Users have full control over angle of ... Pulse masking effects, users are sure to get heads to turn. , ProPanel: Pulse ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... health care in America. As people age, more care is needed, especially with ... rising, and medical professionals are being overworked. The forgotten part of this equation: ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
(Date:11/26/2015)... 26, 2015 ... adds "Global Repaglinide Industry 2015 ... on China Repaglinide Market, 2010-2019" reports ... and information to its online business ... . --> ...
Breaking Medicine Technology: